Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Tokunaga, Y. Imamura, Kenichi Nakamura, Tomoyuki Uchihara, T. Ishimoto, S. Nakagawa, M. Iwatsuki, Y. Baba, Y. Sakamoto, Y. Miyamoto, N. Yoshida, Shinichiro Oyama, Takashi Shono, H. Naoe, H. Saeki, E. Oki, Masayuki Watanabe, Y. Sasaki, Y. Maehara, H. Baba (2015)
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinomaCancer Medicine, 4
S. Levolger, J. Vugt, R. Bruin, J. Ijzermans (2015)
Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignanciesBritish Journal of Surgery, 102
Y. Miyamoto, D. Hanna, Wu Zhang, H. Baba, H. Lenz (2016)
Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer TreatmentClinical Cancer Research, 22
Xiaolan Zhou, Jin Wang, John Lu, Yanping Song, K. Kwak, Q. Jiao, R. Rosenfeld, Qing Chen, T. Boone, W. Simonet, D. Lacey, A. Goldberg, Hq Han (2010)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged SurvivalCell, 142
Lokireddy (2012)
Myostatin is a novel tumoral factor that induces cancer cachexiaBiochem J, 446
Yusuke Katayama, T. Oshima, K. Sakamaki, T. Aoyama, Tsutomu Sato, K. Masudo, M. Shiozawa, T. Yoshikawa, Y. Rino, T. Imada, M. Masuda (2017)
Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy.In vivo, 31 4
(2018)
INHBA upregula‐ tion correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
E. Stok, M. Spaander, D. Grünhagen, C. Verhoef, E. Kuipers (2017)
Surveillance after curative treatment for colorectal cancerNature Reviews Clinical Oncology, 14
Y. Miyamoto, Y. Baba, Y. Sakamoto, M. Ohuchi, R. Tokunaga, J. Kurashige, Y. Hiyoshi, S. Iwagami, N. Yoshida, M. Yoshida, Masayuki Watanabe, H. Baba (2015)
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal CancerAnnals of Surgical Oncology, 22
A. Loumaye, M. Barsy, M. Nachit, P. Lause, Aline Maanen, P. Tréfois, D. Gruson, J. Thissen (2017)
Circulating Activin A predicts survival in cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 8
T. Yoshino, D. Arnold, H. Taniguchi, G. Pentheroudakis, K. Yamazaki, Rui-Hua Xu, Tae Kim, F. Ismail, I. Tan, K. Yeh, A. Grothey, S. Zhang, J. Ahn, M. Mastura, D. Chong, L. Chen, S. Kopetz, T. Eguchi-Nakajima, H. Ebi, A. Ohtsu, A. Cervantes, K. Muro, J. Tabernero, H. Minami, F. Ciardiello, J. Douillard (2018)
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOSAnnals of Oncology, 29
(2015)
Japanese Society of Medical Oncology: Japanese society of medical oncology clinical guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients
M. Okano, Hirofumi Yamamoto, Hisataka Ohkuma, Y. Kano, Hirotoshi Kim, Shimpei Nishikawa, M. Konno, K. Kawamoto, N. Haraguchi, I. Takemasa, T. Mizushima, M. Ikeda, T. Yokobori, K. Mimori, M. Sekimoto, Y. Doki, M. Mori, H. Ishii (2013)
Significance of INHBA expression in human colorectal cancer.Oncology reports, 30 6
Y. Miyamoto, Y. Baba, Y. Sakamoto, M. Ohuchi, R. Tokunaga, J. Kurashige, Y. Hiyoshi, S. Iwagami, N. Yoshida, Masayuki Watanabe, H. Baba (2015)
Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal CancerPLoS ONE, 10
D. Gaddy-Kurten, K. Tsuchida, W. Vale (1995)
Activins and the receptor serine kinase superfamily.Recent progress in hormone research, 50
N. Forones, Marcelo Tanaka (1999)
CEA and CA 19-9 as prognostic indexes in colorectal cancer.Hepato-gastroenterology, 46 26
N. Daitoku, Y. Miyamoto, Yuki Sakamoto, R. Tokunaga, Y. Hiyoshi, Y. Nagai, M. Iwatsuki, S. Iwagami, N. Yoshida, H. Baba (2019)
Prognostic significance of serum p53 antibody according to KRAS status in metastatic colorectal cancer patientsInternational Journal of Clinical Oncology, 25
K. Matsuzaki (2011)
Smad phosphoisoform signaling specificity: the right place at the right timeCarcinogenesis, 32
S. Lokireddy, I. Wijesoma, S. Bonala, M. Wei, S. Sze, C. McFarlane, R. Kambadur, M. Sharma (2016)
Myostatin is a novel tumoral factor that induces cancer cachexiaBiochemical Journal, 473
MA Hoda, J. Münzker, B. Ghanim, K. Schelch, T. Klikovits, V. Laszlo, Emine Sahin, A. Bedeir, Andreas Lackner, B. Dome, U. Setinek, M. Filipits, M. Eisenbauer, I. Kenessey, S. Török, T. Garay, B. Hegedűs, A. Catania, S. Taghavi, W. Klepetko, Walter Berger, M. Grusch (2012)
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cellsBritish Journal of Cancer, 107
K. Harada, S. Ida, S. Ida, Y. Baba, T. Ishimoto, K. Kosumi, R. Tokunaga, Daisuke Izumi, M. Ohuchi, K. Nakamura, Y. Kiyozumi, Y. Imamura, M. Iwatsuki, S. Iwagami, Y. Miyamoto, Y. Sakamoto, N. Yoshida, Masayuki Watanabe, Hideo Baba (2015)
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 29 6
Y. Kitano, Y. Yamashita, Yoichi Saito, S. Nakagawa, H. Okabe, K. Imai, Y. Komohara, Y. Miyamoto, A. Chikamoto, T. Ishiko, H. Baba (2019)
Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic CholangiocarcinomaWorld Journal of Surgery
W. Evans (2010)
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.The American journal of clinical nutrition, 91 4
W. Sauerbrei, S. Taube, L. McShane, M. Cavenagh, D. Altman (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and ElaborationJNCI Journal of the National Cancer Institute, 110
T. Oshima, K. Yoshihara, T. Aoyama, S. Hasegawa, Tsutomu Sato, N. Yamamoto, Nozaki Akito, M. Shiozawa, T. Yoshikawa, K. Numata, Y. Rino, C. Kunisaki, Katsuaki Tanaka, M. Akaike, T. Imada, M. Masuda (2014)
Relation of INHBA gene expression to outcomes in gastric cancer after curative surgery.Anticancer research, 34 5
Yoshino (2018)
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOSAnn Oncol, 29
(2016)
High circu‐ lating activin a level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
F. Bray, J. Ferlay, I. Soerjomataram, R. Siegel, Lindsey Torre, A. Jemal (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 68
Jay Toulany, S. Parlee, C. Sinal, K. Slayter, S. Mcneil, K. Goralski
This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License
I. Janssen, S. Heymsfield, R. Ross (2002)
Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical DisabilityJournal of the American Geriatrics Society, 50
H. Taniguchi, K. Yamazaki, T. Yoshino, K. Muro, Y. Yatabe, Toshiaki Watanabe, H. Ebi, A. Ochiai, E. Baba, K. Tsuchihara (2015)
Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11Cancer Science, 106
Xiaoling Zhong, Marianne Pons, Christophe Poirier, Yanlin Jiang, Jianguo Liu, G. Sandusky, S. Shahda, A. Nakeeb, C. Schmidt, M. House, E. Ceppa, N. Zyromski, Yunlong Liu, Guanglong Jiang, M. Couch, Leonidas Koniaris, T. Zimmers (2018)
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapyJournal of Cachexia, Sarcopenia and Muscle, 10
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
N. Daitoku, Y. Miyamoto, R. Tokunaga, Yuki Sakamoto, Y. Hiyoshi, M. Iwatsuki, Y. Baba, S. Iwagami, N. Yoshida, H. Baba (2018)
Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line ChemotherapyAntiCancer Research, 38
D. Albano, C. Messina, J. Vitale, L. Sconfienza (2019)
Imaging of sarcopenia: old evidence and new insightsEuropean Radiology, 30
Activin A is a member of the transforming growth factor‑β superfamily of cytokines and displays various pathophysiological activities, including regulation of muscle catabolism and atrophy. Activin A expression is upregulated in several human cancer types and in certain pathologies, its expression is associated with poor prognosis. In the present study, activin A expression was assessed in colorectal cancer (CRC) tissue specimens from 157 patients with primary CRC and the relationship between activin A levels and clinicopathological characteristics, including skeletal muscle mass, and prognosis, was determined. Furthermore, the effects of knockdown of endogenous or exposure to exogenous activin A on the malignant behavior of human CRC cell lines were investigated <em>in vitro</em>. The results indicated that activin A mRNA was significantly upregulated in CRC tumor tissues compared with normal intestinal epithelium. High activin A expression was significantly associated with shorter cancer‑specific survival (P=0.047) and overall survival (P=0.014). According to a multivariate analysis, tumor activin A levels were an independent prognostic factor for overall survival (P=0.001). However, activin A mRNA levels were not associated with the skeletal muscle index. The <em>in vitro</em> experiments demonstrated that exposure to exogenous activin A increased the proliferation, invasion and migration of CRC cell lines, whereas knockdown of endogenous activin A had the opposite effects. In conclusion, activin A is an autocrine and paracrine regulator of CRC cell proliferation and high tumor expression of activin A is associated with poor prognosis in patients with CRC.
Oncology Reports – Spandidos Publications
Published: Jun 17, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.